MOLTENI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 4.258
NA - Nord America 4.049
EU - Europa 2.463
SA - Sud America 360
AF - Africa 44
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.179
Nazione #
US - Stati Uniti d'America 3.963
VN - Vietnam 2.227
IT - Italia 778
SG - Singapore 763
CN - Cina 576
DE - Germania 431
HK - Hong Kong 317
RU - Federazione Russa 309
BR - Brasile 292
IE - Irlanda 168
SE - Svezia 154
GB - Regno Unito 126
AT - Austria 90
IN - India 79
ID - Indonesia 76
FI - Finlandia 65
KR - Corea 64
FR - Francia 59
UA - Ucraina 57
CA - Canada 56
ES - Italia 44
PL - Polonia 43
BE - Belgio 33
DK - Danimarca 31
AR - Argentina 26
JP - Giappone 25
TR - Turchia 25
MX - Messico 24
TW - Taiwan 24
BD - Bangladesh 20
CH - Svizzera 19
ZA - Sudafrica 19
NL - Olanda 17
EC - Ecuador 13
CZ - Repubblica Ceca 9
PY - Paraguay 9
IQ - Iraq 8
IR - Iran 8
LT - Lituania 8
CO - Colombia 6
KE - Kenya 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
IL - Israele 4
UZ - Uzbekistan 4
DZ - Algeria 3
EE - Estonia 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LI - Liechtenstein 1
NG - Nigeria 1
OM - Oman 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 11.179
Città #
Ann Arbor 1.022
Ho Chi Minh City 697
Hanoi 577
Singapore 487
Ashburn 344
Frankfurt am Main 316
Hong Kong 315
Chandler 254
Milan 251
Wilmington 210
Dallas 197
Dublin 162
Woodbridge 161
Fairfield 144
Beijing 135
New York 112
Los Angeles 90
Dearborn 83
Vienna 81
Houston 79
Seattle 72
Hefei 71
Haiphong 68
Santa Clara 68
Jakarta 67
Biên Hòa 60
Princeton 58
Da Nang 57
Cambridge 53
Ha Long 48
Quận Bình Thạnh 46
Jacksonville 43
Buffalo 38
São Paulo 37
Shanghai 36
Rome 35
London 34
Munich 34
Helsinki 33
Nanjing 33
Seoul 33
Can Tho 32
Thái Nguyên 32
Hải Dương 31
Quận Một 31
Kent 30
Chicago 27
Brussels 26
Granada 26
Moscow 26
Quận Phú Nhuận 26
Bắc Ninh 25
Ninh Bình 25
Pune 25
Council Bluffs 23
Bắc Giang 22
Guangzhou 22
Warsaw 22
Vũng Tàu 21
Fremont 20
Nuremberg 20
Tokyo 20
Phủ Lý 19
Toronto 19
Lawrence 17
Turku 16
Vinh 16
Kaohsiung 15
Altamura 14
Monza 14
Boardman 13
Boston 13
Denver 13
Nam Định 13
Quận Bảy 13
Quận Sáu 13
Rio de Janeiro 13
Romola 13
San Diego 13
Thu Dau Mot 13
Andover 12
Stockholm 12
Lấp Vò 11
Orem 11
Phoenix 11
Poplar 11
Quảng Ninh 11
Quận Bốn 11
Quận Năm 11
Điện Bàn 11
Carate Brianza 10
Tampa 10
Thanh Hóa 10
Thành Phố Bà Rịa 10
Ankara 9
Brooklyn 9
Huế 9
Hòa Bình 9
Kunming 9
Manchester 9
Totale 7.739
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.027
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 689
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 472
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 448
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 426
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 414
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 408
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 396
Growth hormone secretagogues and the regulation of calcium signaling in muscle 390
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 347
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 308
PHARMACOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR SIGNALLING PATHWAY ACTIVATED BY TLQP-21 304
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 299
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 297
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 273
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 265
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 263
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 248
Parma consensus statement on metabolic disruptors 248
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 241
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 240
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 240
TLQP-21 modulate inflammation and fibrosis in a model of ards 231
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 229
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 223
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 217
The Role of NMNAT2/SARM1 in Neuropathy Development 216
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 209
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 191
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 168
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 167
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 165
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 157
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 136
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 136
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 127
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 109
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 104
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 100
Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system 97
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 95
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 93
Role of nutrition in degenerative disease 80
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 55
Totale 11.548
Categoria #
all - tutte 31.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021657 0 0 0 0 0 101 83 90 87 85 99 112
2021/2022656 91 71 56 52 37 44 22 21 24 58 58 122
2022/20231.122 130 252 140 116 56 172 21 79 75 17 33 31
2023/2024726 26 39 41 53 76 202 121 28 42 13 14 71
2024/20251.993 96 132 118 120 156 120 165 62 131 250 177 466
2025/20264.574 2.138 836 485 574 517 24 0 0 0 0 0 0
Totale 11.548